封面
市場調查報告書
商品編碼
1308720

2030 年預灌封注射器包裝市場預測 - 按材料類型、應用、最終用戶和地區劃分的全球分析

Prefilled Syringe Packaging Market Forecasts to 2030 - Global Analysis By Material Type, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,全球預充式註射器包裝市場在預測期內將以 14% 的複合年增長率增長。

一種稱為預填充注射器包裝的包裝用於在預稱重、預填充注射器中儲存和輸送藥物和疫苗。 它的目的是在施用藥物和疫苗時方便、準確和安全。 預充式註射器含有預定劑量的藥物或疫苗,通常為液體形式,並用防篡改帽或柱塞蓋密封。 注射器由與所包裝的藥物或疫苗相容的材料製成,以確保穩定性並防止污染。

根據美國國家環境健康科學研究所的數據,2017 年,美國有 2400 萬人患有自身免疫性疾病。 此外,800 萬人體內存在自身抗體——表明他們可能患上自身免疫性疾病的血液分子。

市場動態:

驅動程序

安全需求不斷增長

預填充注射器包裝通常使用先進的阻隔材料和特殊密封件,以幫助延長藥物的保質期。 這最大限度地降低了降解風險並保持了藥物的長期穩定性和功效。 預充式註射器還具有防篡改設計,可提供更好的保護。 密封包裝有助於防止污染、意外溢出和篡改,從而降低用藥錯誤的風險。 這些因素正在擴大市場。

限制

包裝成本高

預充式註射器包裝比傳統的小瓶包裝成本更高。 製造程序、特殊材料和額外的質量控制措施都會增加成本。 此外,預充式註射器的使用可能會受到成本增加的限制,特別是在資源有限的醫療保健系統中。

機會:

新興國家醫療保健設施的擴張

醫療保健資金不足仍然是新興經濟體的一個問題,對醫療保健的獲取和質量產生不利影響,進而影響人口的健康。 過去二十年,全球醫療保健支出佔 GDP 的比例估計約為 8% 至近 10%,即每年 8 萬億美元。 這一增長歸因於醫療保健成本的上升、治療選擇的擴大以及消費者需求的增加。 不斷壯大的中產階級、不斷增長的國內生產總值以及不斷增加的政府支出都被認為是推動這一增長的因素。

威脅:

嚴格監管和有限的可重用性

使用預充式註射器可能需要監管部門的批准並遵守某些法規。 這些規定因國家和地區而異,使問題變得複雜,並可能延遲某些預充注射器形式藥物的上市。 此外,預充式註射器不適合重複使用。 這種一次性使用的性質可能會導致更多的醫療廢物,甚至可能阻礙市場擴張。

COVID-19 的影響:

隨著 COVID-19 的爆發,預計世界各地的免疫接種量將大幅增加。 由於注射器的使用如此頻繁,COVID-19 促進了預填充注射器包裝的開發。 還研究了具有不同玻璃筒塗層、容量和其他可能影響其對深度冷凍反應的因素的注射器。 2020 年,受 COVID-19 大流行影響,全球預灌封注射器包裝市場的銷售額出現增長。

酒店業將在預測期內成為最大的行業:

醫院領域將主導市場,糖尿病、心血管疾病和癌症患者的住院人數不斷增加。 酒店業因其多功能性已成為主要用戶。 此外,亞太和非洲發展中國家對醫療基礎設施建設的日益關注也有望刺激該行業的增長。

塑料材料領域預計在預測期內復合年增長率最高:

塑料材料領域預計將在預測期內迅速擴張。 由於這些注射器在醫療機構中的採用率越來越高,並且它們具有保護藥物免受潮濕的能力,預計該市場在預測期內將會增長。

市場份額最高的地區:

由於醫護人員偏愛預充式註射器以減少針刺傷害等因素,預計歐洲將主導預充式註射器包裝市場。 此外,多年來,主要市場參與者也加強了在該地區的影響力。 此外,政府鼓勵使用一次性醫療用品預防傳染病的眾多舉措以及重要市場參與者的存在預計將支持該地區的增長。

複合年增長率最高的地區:

在預測期內,亞太地區預計將出現最高的複合年增長率。 這是由於快速擴張的經濟區的出現和巨大的未開發市場的存在。 此外,由於人口規模大和各種慢性病患病率上升等有利的人口因素,預計該地區的市場將會增長。

主要進展:

2023 年 6 月 - 互聯醫療手術和重症監護病房 (ICU) 床位的創新者 Baxter International Inc. 今天宣佈在美國推出其新的 ICU 病床 Hillrom Progressa+。 Progressa+ 提供新技術和功能,使護士能夠更輕鬆地護理患者,同時支持他們的康復。

2023 年5 月,全球領先的醫療技術公司之一百特國際(Baxter International) 今天宣布,將把其生物製藥解決方案(“BPS”) 業務投資給全球最大、最有經驗的私募股權投資者之一。已達成最終協議,將全球領先的成長型投資者 Advent International(“Advent”)出售給全球領先的成長型投資者 Warburg Pincus(“Warburg”)。

2023 年2 月,注射劑量創新解決方案的全球領導者West Pharmaceutical Services 擴大了與康寧的突破性合作夥伴關係,推出康寧ValorR 玻璃瓶。並宣布推出其首款產品West Ready Pack(TM ) ),使用採用 SG EZ-fill(R) 技術的康寧 Valor(R) RTU 樣品瓶。

報告內容

  • 區域和國家級細分市場的市場份額評估
  • 給新進入者的戰略建議
  • 2021 年、2022 年、2023 年、2026 年和 2030 年的綜合市場數據
  • 市場趨勢(驅動因素、限制因素、機遇、威脅、挑戰、投資機會、建議)
  • 根據市場預測提出關鍵業務領域的戰略建議
  • 競爭格局繪製主要共同趨勢
  • 公司簡介,包括詳細的戰略、財務狀況和最新發展
  • 供應鏈趨勢映射最新技術趨勢

免費定制服務:

訂閱此報告的客戶將獲得以下免費自定義選項之一:

  • 公司簡介
    • 對其他市場參與者(最多 3 家公司)進行全面分析
    • 主要公司的SWOT分析(最多3家公司)
  • 區域細分
    • 根據客戶興趣對主要國家/地區的市場估計/預測/複合年增長率(注:基於可行性檢查)
  • 競爭基準測試
    • 根據產品組合、地域分佈和戰略聯盟對主要參與者進行基準測試

內容

第 1 章執行摘要

第二章前言

  • 執行摘要
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 調查來源
    • 主要研究來源
    • 二手研究來源
    • 先決條件

第三章市場趨勢分析

  • 驅動程序
  • 制約因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠肺炎 (COVID-19) 的影響

第 4 章波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間存在敵對關係

第五章預灌封注射器包裝全球市場(按材料類型)

  • 玻璃材質
  • 塑料材質

第六章預灌封注射器包裝的全球市場(按應用)

  • 疫苗
  • 麻醉劑
  • 抗血栓藥物
  • 生物製品
  • 胰島素製劑

第 7 章預灌封注射器包裝的全球市場:按最終用戶劃分

  • 酒店業
  • 醫務室
  • 家庭護理

第 8 章全球預灌封注射器包裝市場:按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 亞太地區其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東和非洲地區

第 9 章主要進展

  • 合同、合作夥伴關係、聯盟和合資企業
  • 收購與合併
  • 推出新產品
  • 業務擴展
  • 其他關鍵策略

第 10 章公司簡介

  • Baxter
  • Becton Dickinson
  • Bespak
  • Bosch Packaging
  • Catalent
  • Ciron Group
  • Corden Pharma
  • Gerresheimer
  • Health Biotech
  • MedXL
  • Nipro
  • Novalek Pharmaceuticals
  • Schott
  • Stevanato Group
  • Troikaa
  • Vetter Pharma
  • West Pharmaceutical Services
  • Ypsomed Holding
Product Code: SMRC23420

According to Stratistics MRC, the Global Prefilled Syringe Packaging Market is growing at a CAGR of 14% during the forecast period. In order to store and deliver medications or vaccines in premeasured and prefilled syringes, a type of packaging known as prefilled syringe packaging is used. When administering medications or vaccines, it is intended to be convenient, accurate, and safe. Prefilled syringes contain a predetermined dosage of medication or a vaccine, usually in liquid form, and are sealed with a tamper-evident cap or plunger cover. The syringes are made of materials that are compatible with the drug or vaccine being packaged to ensure stability and prevent contamination.

According to the National Institute of Environmental Health Science, in 2017, 24 million people had a condition of autoimmune disease in the US. Moreover, 8 million people had auto-antibodies-blood molecules that indicate a person's chance of developing autoimmune disease.

Market Dynamics:

Driver:

Rising need for safety

Advanced barrier materials and specialized seals are frequently found in prefilled syringe packaging, which can aid in extending the shelf life of pharmaceuticals. This minimizes the risk of degradation and ensures that the medication is stable and effective for a longer time. Prefilled syringes also feature a tamper-evident design that adds an extra measure of protection. The risk of medication errors is decreased by the sealed packaging, which helps prevent contamination, unintentional spills, and tampering. As a result of such factors, the market is expanding.

Restraint:

High of packaging

Packaging for prefilled syringes can cost more than packaging for conventional vials. The cost is higher due to the manufacturing procedure, specialized materials, and additional quality control measures. Moreover, prefilled syringe use may be restricted by this increased cost, particularly in healthcare systems with limited resources.

Opportunity:

Expanding healthcare facilities in emerging economies

Inadequate healthcare funding continues to be a problem in emerging nations, which has a negative impact on healthcare access, quality, and ultimately, citizen health. In the past two decades, the share of total global healthcare spending in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion annually. This increase is attributed to the rising costs of medical care, the expansion of treatment options, and rising consumer demands. The expansion of the middle class, rising GDP, and increased government spending may all be contributing factors to this growth.

Threat:

Stringent regulations and limited reusability

Prefilled syringe use might necessitate regulatory approval and adherence to particular rules. These rules differ between nations and regions, which complicates matters and might cause a delay in the release of some medications in prefilled syringe form. Additionally, prefilled syringes aren't made to be reused; they're typically only meant to be used once. Due to this single-use nature, more medical waste may be produced, which even inhibits market expansion.

COVID-19 Impact:

An enormous increase in vaccinations is anticipated worldwide as a result of COVID-19 outbreaks. Because syringes are used so frequently, COVID-19 has prompted the development of prefilled syringe packaging. Syringes with different glass barrel coatings, volumes, and other factors that might affect how they react to deep freezing were also studied. The global prefilled syringe packaging market saw an increase in sales as a result of the COVID-19 pandemic's outbreak in 2020.

The hospitals segment is expected to be the largest during the forecast period:

A growing number of patients with diabetes, cardiovascular diseases, and cancer were admitted into hospitals, which led to the hospital segment dominating the market. Because of the variety of applications, hospitals are the main users. A further factor that is anticipated to spur the segment's growth is the growing emphasis on the construction of healthcare infrastructure in developing nations in Asia Pacific and Africa.

The plastic material segment is expected to have the highest CAGR during the forecast period:

The plastic material segment is expected to expand quickly over the forecast period. As a result of these syringes' increased adoption by healthcare facilities and ability to shield drugs from moisture, the market will grow during the anticipated period.

Region with largest share:

Due to factors like the preference of healthcare professionals for prefilled injectable devices to reduce needle-related injuries, Europe is predicted to dominate the prefilled syringes packaging market. Major market players have also bolstered their presence in the area over the years. Additionally, a number of government initiatives to encourage the use of single-use medical supplies to prevent infections, along with the presence of significant market players, are anticipated to support regional growth.

Region with highest CAGR:

Over the forecast period, Asia-Pacific is anticipated to experience the highest CAGR. This is a result of the emergence of rapidly expanding economies and the existence of a sizable untapped market. Additionally, the region's market is anticipated to grow as a result of favorable demographic factors like the large population and rising prevalence of different chronic diseases.

Key players in the market

Some of the key players profiled in the Prefilled Syringe Packaging Market include Baxter, Becton Dickinson, Bespak, Bosch Packaging, Catalent, Ciron Group, Corden Pharma, Gerresheimer, Health Biotech, MedXL, Nipro, Novalek Pharmaceuticals, Schott, Stevanato Group, Troikaa, Vetter Pharma, West Pharmaceutical Services and Ypsomed Holding.

Key Developments:

In June 2023, Baxter International Inc., an innovator in connected beds for med-surg and the intensive care unit (ICU), announced today the U.S. launch of its new Hillrom Progressa+ bed for the ICU. Progressa+ offers new technology and features that help make it easier for nurses to care for patients, while supporting patient recovery.

In May 2023, Baxter International Inc., a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions ("BPS") business to Advent International ("Advent"), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.

In February 2023, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announces the expansion of its landmark collaboration with Corning Incorporated, that now includes the exclusive distribution rights for Corning Valor® Glass vials and the launch of its first product, West Ready Pack™ with Corning Valor® RTU Vials utilizing SG EZ-fill® technology.

Material Types Covered:

  • Glass Material
  • Plastic Material

Applications Covered:

  • Vaccines
  • Anesthetics
  • Antithrombotic Drugs
  • Biologics
  • Insulin

End Users Covered:

  • Hospitals
  • Clinics
  • Home Care

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Prefilled Syringe Packaging Market, By Material Type

  • 5.1 Introduction
  • 5.2 Glass Material
  • 5.3 Plastic Material

6 Global Prefilled Syringe Packaging Market, By Application

  • 6.1 Introduction
  • 6.2 Vaccines
  • 6.3 Anesthetics
  • 6.4 Antithrombotic Drugs
  • 6.5 Biologics
  • 6.6 Insulin

7 Global Prefilled Syringe Packaging Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Home Care

8 Global Prefilled Syringe Packaging Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Baxter
  • 10.2 Becton Dickinson
  • 10.3 Bespak
  • 10.4 Bosch Packaging
  • 10.5 Catalent
  • 10.6 Ciron Group
  • 10.7 Corden Pharma
  • 10.8 Gerresheimer
  • 10.9 Health Biotech
  • 10.10 MedXL
  • 10.11 Nipro
  • 10.12 Novalek Pharmaceuticals
  • 10.13 Schott
  • 10.14 Stevanato Group
  • 10.15 Troikaa
  • 10.16 Vetter Pharma
  • 10.17 West Pharmaceutical Services
  • 10.18 Ypsomed Holding

List of Tables

  • Table 1 Global Prefilled Syringe Packaging Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 3 Global Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 4 Global Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 5 Global Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 6 Global Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 7 Global Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 8 Global Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 9 Global Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 10 Global Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 11 Global Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 12 Global Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 13 Global Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 14 Global Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 15 North America Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 16 North America Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 17 North America Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 18 North America Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 19 North America Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 20 North America Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 21 North America Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 22 North America Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 23 North America Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 24 North America Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 25 North America Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 North America Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 27 North America Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 28 North America Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 29 Europe Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 30 Europe Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 31 Europe Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 32 Europe Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 33 Europe Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 34 Europe Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 35 Europe Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 36 Europe Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 37 Europe Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 38 Europe Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 39 Europe Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 40 Europe Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 41 Europe Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 42 Europe Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 43 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 45 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 46 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 47 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 48 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 49 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 50 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 51 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 52 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 53 Asia Pacific Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 54 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 55 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 56 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 57 South America Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 58 South America Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 59 South America Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 60 South America Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 61 South America Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 62 South America Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 63 South America Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 64 South America Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 65 South America Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 66 South America Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 67 South America Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 68 South America Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 69 South America Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 70 South America Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 71 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 72 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 73 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 74 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 75 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 76 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 77 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 78 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 79 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 80 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 81 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 82 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 83 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 84 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)